We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Dr Izhar Hasan is the Chief Scientific Officer and CO- founder of RHNanopharmacuticals, LLC.
Dr. Hasan, is a family physician with a sub specialty board certification in clinical informatics. Dr Hasan has strong academic interests and has a PhD in medical informatics. Dr Hasan has extensively published in journals such Lancet, Cancer research, and pediatric neurosurgery. His work has been published about Nitric oxide-NSAIDS compounds in early part of his career. Dr Hasan strongly believes in the pluripotent properties of Salsalate with innovative nano formulation. Dr Hasan was instrumental in a successful Pre IND meeting with FDA in paving the 505 B (2)regulatory pathway for Salsalate program development.
This speaker's sessions: